infliximab
janssen
['infliximab', 'danbio', 'imab ']
danbio registry plenary abs 1112 finds 1 yr retention following a mandatory nationwide infliximab biosimilar-to-biosimilar switch was high. retention higher in originator-experienced and in pts w/ low disease activity. #acr22 
Passionately curious rheumatologist, world traveler, wife, mother, sister, daughter, friend, dog lover. Believer in scientific method & evidence based medicine.